FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

BAYER DIAGNOSTICS ADVIA CENTAUR TOXOPLASMA IGM ASSAY

K Number: K010755 · Decision Aug 20, 2001
Classifications
1
FEI Numbers
32
Registration Numbers
32
Same Product Code
105
Applicant Total
96
Review Days
160

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
BAYER DIAGNOSTICS ADVIA CENTAUR TOXOPLASMA IGM ASSAY
K Number
K010755
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
866.3780
Medical Specialty
Microbiology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Bayer Corp.
Date Received
March 13, 2001
Decision Date
August 20, 2001
Product Code
LGD
Advisory Committee
Microbiology
Review Advisory Committee
MI
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LGD Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (LGD), ordered by most recent decision date.

View all

Other Clearances by Bayer Corp.

K Number Device Name
K024062 ASCENSIA BREEZE BLOOD GLUCOSE METER
K023944 BAYER DIAGNOSTICS CLINITEST PREGNANCY TEST
K024017 BAYER ADVIA CENTAUR HER-2/NEU ASSAY
K024234 ASCENSIA GLUCOFACTS; ASCENSIA GLUCOFACTS PROFESSIONAL
K022288 COMPLEXED PROSTATE SPECIFIC ANTIGEN (CPSA) ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEM
K023584 ASCENSIA DEX 2 DIABETES CARE SYSTEM
K020828 CA 125 ASSAY FOR THE ADVIA CENTAUR SYSTEM
K021428 CLINITEK ATLAS PRO 12 REAGENT PAK SYSTEM
K020806 ACS:180 & ADVIA CENTAUR AFP IMMUNOASSAY
K013568 CEA ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM
Search all 96 clearances from Bayer Corp. →